Hacker News
new
top
best
ask
show
job
EC Approves Tepkinly as First Bispecific-Based Therapy for Follicular Lymphoma
(
www.biopharminternational.com
)
1 point
by
consumer451
an hour ago
1 comment
tippa123
an hour ago
Because your title mentions EC, I just learned it’s the EC that approves the market authorisation. I always thought it was the EMA but apparently this is “just” a recommendation and in some cases the EC and EMA disagree.